PROK
ProKidney Corp.
1.70$
+0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.9% | -7.8% | +28.7% | -4.9% | -7.1% | -7.9% | -8.4% | -5.5% | -4.6% | -12.8% | -14.9% | |
| – | -7.9% | -9.1% | +32.4% | -4.5% | -8.0% | -9.1% | -9.8% | -7.5% | -6.4% | -16.3% | -19.2% | |
| – | -68.3% | +39.1% | +154.2% | -49.6% | -8.3% | -1.3% | -13.2% | +12.2% | +13.9% | -6.1% | -26.5% | |
| – | -8.4% | -9.4% | +31.2% | -5.7% | -11.9% | -8.3% | -10.3% | -7.8% | -0.6% | -16.7% | -19.3% | |
| – | +92.6% | +38.4% | +44.4% | +85.7% | -52.0% | -28.4% | +1.3% | -30.3% | -8.9% | -8.4% | -7.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +23.7% | -15.4% | +8.4% | +16.9% | +25.9% | -8.5% | -9.4% | +1.8% | +4.5% | -14.7% | -11.8% | |
| – | +19.3% | -22.9% | +6.7% | +22.3% | +43.8% | -9.4% | -13.9% | +2.8% | +5.8% | -15.6% | -12.4% | |
| – | +18.8% | +36.0% | -5.5% | +3.4% | -28.3% | +12.0% | +5.4% | +9.7% | +8.1% | +3.5% | +1.9% | |
| – | +13.9% | -33.8% | -13.1% | -2.8% | +27.5% | -14.1% | -21.7% | -20.5% | -51.6% | +175.7% | -37.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.8% | +1.8% | +24.5% | +66.2% | +1.5% | +0.7% | +1.4% | +3.3% | +4.0% | +1.1% | +31.5% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.